A detailed history of Neos Investment Management LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Neos Investment Management LLC holds 17,936 shares of BPMC stock, worth $1.62 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
17,936
Previous 13,498 32.88%
Holding current value
$1.62 Million
Previous $1.45 Billion 14.04%
% of portfolio
0.05%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$84.1 - $120.5 $373,235 - $534,779
4,438 Added 32.88%
17,936 $1.66 Billion
Q2 2024

Aug 14, 2024

BUY
$85.18 - $108.78 $712,445 - $909,835
8,364 Added 162.91%
13,498 $1.45 Billion
Q1 2024

May 13, 2024

BUY
$73.17 - $99.79 $10,975 - $14,968
150 Added 3.01%
5,134 $487 Million
Q4 2023

Feb 13, 2024

BUY
$43.96 - $92.84 $219,096 - $462,714
4,984 New
4,984 $460 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.4B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.